EUVIMEDEUVIMED entdecken
Beobachtungsstudie

Clinical profile and outcome of patients with ANCA-associated vasculitis with special reference to vasculitis damage index: a longitudinal observational study

Sonali Dey, Arghya Chattopadhyay, Kaustav Bhowmick, Partha Ghorai, Biswadip Ghosh, Mavidi Sunil Kumar, Gautam Raj Panjabi, Angan Karmakar, Pradyot Sinhamahapatra

Rheumatology International · 2025

DOI: 10.1007/s00296-025-06035-7 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Rheumatology International, 2025. Verfasst von Sonali Dey und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Immunology and Rheumatology, Institute of Postgraduate Medical Education and Research, 244, A. J. C. Bose Road, Kolkata, West …. Hauptthemen laut MEDLINE: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Immunosuppressive Agents, Granulomatosis with Polyangiitis. Die Arbeit nennt 29 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Antineutrophil cytoplasmic autoantibody-associated vasculitis (AAV) is the most commonly encountered primary small-vessel vasculitis, with an annual incidence of 20 per million. The data on AAV from the Southeast Asian ethnicity is scarce. The present longitudinal observational study was undertaken to determine the clinical profile and outcomes in fifty-eight consecutive patients of AAV attending the Department of Rheumatology in a tertiary care centre in India. The majority (39, 67.2%) were females with a mean (± SD) age at baseline of 39.2 (± 15.2) years. Granulomatosis with polyangiitis (GPA) was the most common phenotype, accounting for 40 cases (69.0%). The patients were followed up for a mean (± SD) duration of 35.4 (± 31.4) months. The most commonly affected organ domains were the respiratory (46, 79.3%), musculoskeletal (41, 70.7%), and the renal domains (38, 65.5%). In our cohort, a significantly higher number of patients exhibited ophthalmological involvement (31, 53.4%). There were a total of 22 relapse events among 11 patients, representing a relapse rate of 19%. The case-fatality rate was 10.6%. The majority received treatment with intravenous methylprednisolone (46; 79.3%) and intravenous cyclophosphamide (42; 72.4%) during the induction phase, while rituximab (28; 48.3%) was the preferred first-line maintenance agent. BVAS of 22.5 was related to VDI ≥ 5 (p = 0.000). The mean (± SD) Vasculitis Damage Index (VDI) accrued was 2.41 (± 1.97). The most common treatment-related damage included osteoporosis (40%), diabetes (40%), and cataract (13%), whereas the common disease-related damage included diastolic hypertension (58%) and impaired lung function (27%). Higher Birmingham Vasculitis Activity Score (BVAS) at presentation (OR: 1.25, 95% CI 1.031-1.522) and relapse of scleritis (OR: 35.27, 95% CI 1.152 -1000.000) were found to be independent predictors of high VDI ≥ 5. This is the first study from Eastern India that has looked into the clinical profile of AAV and its damage index.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-Neutrophil Cytoplasmic Antibody-Associated VasculitisImmunosuppressive AgentsGranulomatosis with PolyangiitisHumansFemaleMaleLongitudinal StudiesMiddle AgedAdultIndiaRecurrenceTreatment OutcomeSeverity of Illness IndexAgedYoung Adult

Stichwörter der Autor:innen

Anti-neutrophil cytoplasmic antibody-associated vasculitisIndiaObservational studies as topic

Substanzen

Immunosuppressive Agents

Autor:innen und Institutionen

  • Department of Clinical Immunology and Rheumatology, Institute of Postgraduate Medical Education and Research, 244, A. J. C. Bose Road, Kolkata, West Bengal, 700020, India.
  • Department of Clinical Immunology and Rheumatology, Asian Institute of Immunology and Rheumatology, Kolkata, West Bengal, India.
  • Department of Internal Medicine, North Bengal Medical College and Hospital, Siliguri, West Bengal, India.
  • Sunil Rheumatology and Immunology Center, Sector 3, MVP Colony, Visakhapatnam, Andhra Pradesh, 530017, India.
  • Department of Clinical Immunology and Rheumatology, Medanta Superspeciality Hospital, Madhya Pradesh, Indore, 452010, India.
  • Department of General Medicine, Nilratan Sircar Medical College, 138, AJC Bose Road, Kolkata, West Bengal, 700014, India.

Zitieren

APA

Dey, S., Chattopadhyay, A., Bhowmick, K., Ghorai, P., Ghosh, B., Kumar, M. S., Panjabi, G. R., Karmakar, A., & Sinhamahapatra, P. (2025). Clinical profile and outcome of patients with ANCA-associated vasculitis with special reference to vasculitis damage index: a longitudinal observational study. Rheumatology International. https://doi.org/10.1007/s00296-025-06035-7

Vancouver

Dey S, Chattopadhyay A, Bhowmick K, Ghorai P, Ghosh B, Kumar MS, et al. Clinical profile and outcome of patients with ANCA-associated vasculitis with special reference to vasculitis damage index: a longitudinal observational study. Rheumatology International. 2025. doi:10.1007/s00296-025-06035-7

BibTeX
@article{Dey2025,
  author = {Dey, Sonali and Chattopadhyay, Arghya and Bhowmick, Kaustav and Ghorai, Partha and Ghosh, Biswadip and Kumar, Mavidi Sunil and Panjabi, Gautam Raj and Karmakar, Angan and Sinhamahapatra, Pradyot},
  title = {Clinical profile and outcome of patients with ANCA-associated vasculitis with special reference to vasculitis damage index: a longitudinal observational study},
  journal = {Rheumatology International},
  year = {2025},
  doi = {10.1007/s00296-025-06035-7}
}
Kostenlos starten →